ASK REDCHAT ANYTHING ABOUT ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP)
Listen to this Section
$5.14
+0.8350
(
+19.42% )
679.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| ORMD-0801 (ORA-D-013-1)DetailsDiabetes, Type 2 diabetes |
Phase 3 |
| ORMD-0801DetailsNon-alcoholic steatohepatitis , Liver disease |
Phase 2 |
Market Data
|
| Open |
$5.14 |
| Previous Close |
$4.30 |
| Volume |
679.0K |
| Market Cap |
$175.98M |
| Day Range |
$4.21 - $5.19 |
| 52 Week Range |
$1.98 - $5.19 |
| Shares Outstanding |
40.93M |
| Change % |
+19.42% |
| Net Change |
▲ 0.8350 |
| Insider Ownership |
-0.10% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2004 |
| Country | Israel |
Insider Ownership Transactions
Total Amount Purchased:
-1,265,850.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-01-08 |
Sale |
-30000.00 |
Mayer Arie |
| 2024-01-08 |
Sale |
-30000.00 |
Aghion Daniel |
| 2024-01-08 |
Sale |
-30000.00 |
Shapiro Benjamin |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
14 |
Nov 17, 2025 |
| 8-k |
8K-related |
13 |
Nov 17, 2025 |
| 8-a12b |
Other |
3 |
Nov 17, 2025 |
| schedule |
Other |
1 |
Nov 14, 2025 |
| 10-q |
Quarterly Reports |
79 |
Nov 13, 2025 |
| 8-k |
8K-related |
14 |
Oct 24, 2025 |
| 8-k |
8K-related |
12 |
Oct 06, 2025 |
| 8-k |
8K-related |
12 |
Aug 21, 2025 |
| 10-q |
Quarterly Reports |
78 |
Aug 14, 2025 |
| 8-k |
8K-related |
13 |
Jul 23, 2025 |